Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-11-26 Purchase | 2024-11-26 4:58 pm | Lineage Cell Therapeutics Inc. | LCTX | Howe Jill Ann Chief Financial Officer | 15,000 | $0.59 | $8,850 | 25,500 (Direct) | View |
| 2024-11-26 Purchase | 2024-11-26 4:55 pm | Lineage Cell Therapeutics Inc. | LCTX | Samuel George A. III General Counsel | 15,000 | $0.6 | $9,000 | 22,184 (Direct) | View |
| 2024-11-22 Purchase | 2024-11-25 4:30 pm | Lineage Cell Therapeutics Inc. | LCTX | Mulroy Michael H. Director | 40,000 | $0.566 | $22,640 | 298,555 (Direct) | View |
| 2024-11-21 Purchase | 2024-11-22 09:00 am | Lineage Cell Therapeutics Inc. | LCTX | Culley Brian M President and CEO | 40,000 | $0.6 | $24,000 | 194,842 (Direct) | View |
| 2024-08-16 Purchase | 2024-08-19 6:24 pm | Lineage Cell Therapeutics Inc. | LCTX | Howe Jill Ann Chief Financial Officer | 10,500 | $0.89 | $9,345 | 10,500 (Direct) | View |
| 2024-05-24 Purchase | 2024-05-28 09:11 am | Lineage Cell Therapeutics Inc. | LCTX | Culley Brian M President and CEO | 10,000 | $1.05 | $10,500 | 154,842 (Direct) | View |
| 2024-02-08 Purchase | 2024-02-08 7:00 pm | Lineage Cell Therapeutics Inc. | LCTX | BAILEY DON M Director | 96,155 | $1.04 | $100,001 | 158,801 (Indirect) | View |
| 2024-02-06 Purchase | 2024-02-08 6:58 pm | Lineage Cell Therapeutics Inc. | LCTX | BROADWOOD PARTNERS L.P. BROADWOOD CAPITAL INC BRADSHER NEAL C Director 10% Owner | 6,730,770 | $1.04 | $7,000,001 | 83,420,138 (Indirect Direct) | View |
| 2023-12-29 Purchase | 2024-01-02 7:08 pm | Lineage Cell Therapeutics Inc. | LCTX | Jayasuriya Anula Director | 10,000 | $1.09 | $10,900 | 10,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-07-01 Option Award | 2024-07-03 5:00 pm | N/A 2034-07-01 | Lineage Cell Therapeutics Inc. | LCTX | Mulroy Michael H. Director | 75,000 | $0 | 75,000 (Direct) | View |
| 2024-07-01 Option Award | 2024-07-03 5:00 pm | N/A 2034-07-01 | Lineage Cell Therapeutics Inc. | LCTX | Russell Angus C. Director | 75,000 | $0 | 75,000 (Direct) | View |
| 2024-07-01 Option Award | 2024-07-03 5:00 pm | N/A 2034-07-01 | Lineage Cell Therapeutics Inc. | LCTX | BAILEY DON M Director | 75,000 | $0 | 75,000 (Direct) | View |
| 2024-07-01 Option Award | 2024-07-03 5:00 pm | N/A 2034-07-01 | Lineage Cell Therapeutics Inc. | LCTX | Jayasuriya Anula Director | 75,000 | $0 | 75,000 (Direct) | View |
| 2024-07-01 Option Award | 2024-07-03 5:00 pm | N/A 2034-07-01 | Lineage Cell Therapeutics Inc. | LCTX | ANDREWS DEBORAH J Director | 75,000 | $0 | 75,000 (Direct) | View |
| 2024-07-01 Option Award | 2024-07-03 5:00 pm | N/A 2034-07-01 | Lineage Cell Therapeutics Inc. | LCTX | Amin Dipti Director | 75,000 | $0 | 75,000 (Direct) | View |
| 2024-07-01 Option Award | 2024-07-03 2:00 pm | N/A 2034-07-01 | Lineage Cell Therapeutics Inc. | LCTX | BRADSHER NEAL C Director 10% Owner | 75,000 | $0 | 305,000 (Direct) | View |
| 2024-03-07 Option Award | 2024-03-08 4:05 pm | N/A 2034-03-07 | Lineage Cell Therapeutics Inc. | LCTX | Culley Brian M President and CEO | 1,900,000 | $0 | 1,900,000 (Direct) | View |
| 2024-03-07 Option Award | 2024-03-08 4:05 pm | N/A 2034-03-07 | Lineage Cell Therapeutics Inc. | LCTX | Samuel George A. III General Counsel/Secretary | 650,000 | $0 | 650,000 (Direct) | View |
| 2024-03-07 Option Award | 2024-03-08 4:05 pm | N/A 2034-03-07 | Lineage Cell Therapeutics Inc. | LCTX | Howe Jill Ann Chief Financial Officer | 650,000 | $0 | 650,000 (Direct) | View |
| 2024-02-11 Tax Withholding | 2024-02-12 9:30 pm | N/A N/A | Lineage Cell Therapeutics Inc. | LCTX | Samuel George A. III General Counsel/Secretary | 2,490 | $1.08 | 19,335 (Direct) | View |
| 2024-02-11 Exercise | 2024-02-12 9:30 pm | N/A N/A | Lineage Cell Therapeutics Inc. | LCTX | Samuel George A. III General Counsel/Secretary | 6,076 | $0 | 19,335 (Direct) | View |
| 2024-02-11 Tax Withholding | 2024-02-12 9:27 pm | N/A N/A | Lineage Cell Therapeutics Inc. | LCTX | Culley Brian M President and CEO | 12,806 | $1.08 | 207,341 (Direct) | View |
| 2024-02-11 Exercise | 2024-02-12 9:27 pm | N/A N/A | Lineage Cell Therapeutics Inc. | LCTX | Culley Brian M President and CEO | 31,249 | $0 | 207,341 (Direct) | View |
| 2023-07-01 Option Award | 2023-07-03 5:46 pm | N/A 2033-07-01 | Lineage Cell Therapeutics Inc. | LCTX | Mulroy Michael H. Director | 50,000 | $0 | 50,000 (Direct) | View |
| 2023-07-01 Option Award | 2023-07-03 5:46 pm | N/A 2033-07-01 | Lineage Cell Therapeutics Inc. | LCTX | BAILEY DON M Director | 50,000 | $0 | 50,000 (Direct) | View |
| 2023-07-01 Option Award | 2023-07-03 5:46 pm | N/A 2033-07-01 | Lineage Cell Therapeutics Inc. | LCTX | Amin Dipti Director | 50,000 | $0 | 50,000 (Direct) | View |
| 2023-07-01 Option Award | 2023-07-03 5:46 pm | N/A 2033-07-01 | Lineage Cell Therapeutics Inc. | LCTX | Russell Angus C. Director | 50,000 | $0 | 50,000 (Direct) | View |
| 2023-07-01 Option Award | 2023-07-03 5:46 pm | N/A 2033-07-01 | Lineage Cell Therapeutics Inc. | LCTX | ANDREWS DEBORAH J Director | 50,000 | $0 | 50,000 (Direct) | View |
| 2023-07-01 Option Award | 2023-07-03 5:46 pm | N/A 2033-07-01 | Lineage Cell Therapeutics Inc. | LCTX | KINGSLEY ALFRED D Chairman | 50,000 | $0 | 50,000 (Direct) | View |
| 2023-07-01 Option Award | 2023-07-03 5:45 pm | N/A 2033-07-01 | Lineage Cell Therapeutics Inc. | LCTX | Jayasuriya Anula Director | 50,000 | $0 | 50,000 (Direct) | View |
| 2023-07-01 Option Award | 2023-07-03 4:23 pm | N/A 2033-07-01 | Lineage Cell Therapeutics Inc. | LCTX | BRADSHER NEAL C Director 10% Owner | 50,000 | $0 | 230,000 (Direct) | View |
| 2023-03-09 Option Award | 2023-03-10 7:06 pm | N/A 2033-03-09 | Lineage Cell Therapeutics Inc. | LCTX | Hogge Gary S. SVP,Clinical & Medical Affairs | 400,000 | $0 | 400,000 (Direct) | View |
| 2023-03-09 Option Award | 2023-03-10 7:05 pm | N/A 2033-03-09 | Lineage Cell Therapeutics Inc. | LCTX | Samuel George A. III General Counsel/Secretary | 650,000 | $0 | 650,000 (Direct) | View |
| 2023-03-09 Option Award | 2023-03-10 7:03 pm | N/A 2033-03-09 | Lineage Cell Therapeutics Inc. | LCTX | Culley Brian M President and CEO | 1,900,000 | $0 | 1,900,000 (Direct) | View |
| 2023-03-09 Option Award | 2023-03-10 7:02 pm | N/A 2033-03-09 | Lineage Cell Therapeutics Inc. | LCTX | Howe Jill Ann Chief Financial Officer | 150,000 | $0 | 150,000 (Direct) | View |
Ownership | 2023-02-14 4:16 pm | N/A N/A | Lineage Cell Therapeutics Inc. | LCTX | KINGSLEY ALFRED D Director | 0 | $0 | 6,849,242 (Indirect) | View |
| 2022-12-01 Ownership | 2023-02-14 4:16 pm | N/A N/A | Lineage Cell Therapeutics Inc. | LCTX | KINGSLEY ALFRED D Director | 25,000 | $0 | 6,849,242 (Direct) | View |
| 2023-02-11 Tax Withholding | 2023-02-14 4:15 pm | N/A N/A | Lineage Cell Therapeutics Inc. | LCTX | Culley Brian M President and CEO | 12,744 | $1.35 | 220,147 (Direct) | View |
| 2023-02-11 Exercise | 2023-02-14 4:15 pm | N/A N/A | Lineage Cell Therapeutics Inc. | LCTX | Culley Brian M President and CEO | 31,249 | $0 | 220,147 (Direct) | View |
| 2023-02-11 Tax Withholding | 2023-02-14 4:15 pm | N/A N/A | Lineage Cell Therapeutics Inc. | LCTX | Samuel George A. III General Counsel/Secretary | 2,478 | $1.35 | 21,825 (Direct) | View |
| 2023-02-11 Exercise | 2023-02-14 4:15 pm | N/A N/A | Lineage Cell Therapeutics Inc. | LCTX | Samuel George A. III General Counsel/Secretary | 6,076 | $0 | 21,825 (Direct) | View |
| 2023-02-11 Tax Withholding | 2023-02-14 4:15 pm | N/A N/A | Lineage Cell Therapeutics Inc. | LCTX | Hogge Gary S. SVP,Clinical & Medical Affairs | 5,310 | $1.35 | 46,771 (Direct) | View |
| 2023-02-11 Exercise | 2023-02-14 4:15 pm | N/A N/A | Lineage Cell Therapeutics Inc. | LCTX | Hogge Gary S. SVP,Clinical & Medical Affairs | 13,020 | $0 | 46,771 (Direct) | View |
| 2022-11-14 Option Award | 2022-11-16 4:17 pm | N/A 2032-11-14 | Lineage Cell Therapeutics Inc. | LCTX | Howe Jill Ann Chief Financial Officer | 1,000,000 | $0 | 1,000,000 (Direct) | View |
Ownership | 2022-07-08 6:25 pm | N/A 2029-09-01 | Lineage Cell Therapeutics Inc. | LCTX | Hernandez Alexandra Sr Director Finance/Controller | 0 | $0 | 219,892 (Direct) | View |